Skip to main content

Resources and News

Learn more about the ongoing effects of prior authorization on patients and physicians over the years.
Explore relevant resources and news.

News | AMA

Geisinger is taking sting out of prior authorization for doctors

Leaders at Geisinger wanted to reduce physician burnout so they tackled one of the biggest headaches in medical practice today: prior authorization. A pharmacy team now handles all requests, saving Geisinger clinics up to fours a week and boosting payer approval rates by 30%.

News | Axios

Optum to drop prior authorization requirement for dozens of drugs

Optum Rx — which includes the pharmacy benefit manager of health care conglomerate UnitedHealth Group — is dropping annual reauthorization requirements for 80 drugs, which will eliminate more than 10% of overall pharmacy prior authorizations.

News | Becker’s Payer Issues

UnitedHealthcare to cut prior authorization by 10%

In a March 1 notice to providers, UnitedHealthcare said it will eliminate prior authorizations for home health services that apply to Medicare Advantage and dual special needs plans in more than 30 states.

News | The Guardian

My $30,000 health insurance claim was denied. Then I tweeted about it

Social media outreach is not the conventional avenue through which to challenge health insurance-related delays and denials, but it can be effective. Miranda Yaver shares her story and struggle with insurers deeming her treatment “medically unnecessary.”

News | AMA

Physicians concerned AI increases prior authorization denials

Many physicians fear the health insurance industry’s use of unregulated artificial intelligence automation and predictive technologies will increasingly override good medical judgment and systematically deny patients coverage for necessary medical care.

News | Physician Leadership

States Target Health Insurers’ ‘Prior Authorization’ Red Tape

The current prior authorization process creates barriers to necessary medical treatment, causing frustration and potential harm to patients. Christopher Marks shares his struggle with insurers to get Mounjaro – the medication he needs for his Type 2 diabetes.